Trade Mark Journal No.2025/048 28 November 2025

WO0000001887070 (5)

Office of origin: United States of America

Date of International Registration:15 October 2025
Date of designation in the UK: 15 October 2025
Image for mark 1887070 OXNIMBI

Class 5
Pharmaceutical preparations for the treatment of obstructive sleep apnea, symptomatic snoring, and sleep disorders.

Apnimed, Inc.

Representative: Sean McConnell Troutman Pepper Locke LLP, EIGHTEENTH AND ARCH STREETS, 3000 TWO LOGAN SQUARE, Philadelphia PA 19103-2799, UNITED STATES OF AMERICA